Literature DB >> 18265958

[Surgical and instrumental management of benign prostatic hyperplasia].

R Muschter1, O Reich.   

Abstract

In recent decades, several various interventional procedures for the treatment of symptomatic benign prostatic hyperplasia (BPH) have been developed. Most of them were considered potential alternatives to prostatic surgery such as open prostatectomy, transurethral resection of the prostate (TURP), or transurethral incision of the prostate (TUIP). Despite good results observed in the initial clinical studies, most concepts and procedures were never generally accepted. However, they contributed considerably to general knowledge regarding the treatment of symptomatic and obstructive BPH. Only a few procedures could stand the test of time and became part of the urological armamentarium. Currently, interventional therapies are classified by their effects on prostate tissue: procedures with immediate tissue ablation (open prostatectomy, TURP, vaporization techniques, laser resection techniques), thermal coagulating procedures with delayed tissue ablation (transurethral high-energy microwave thermotherapy, transurethral needle ablation, interstitial laser coagulation), and other procedures (TUIP, stents) with deobstruction effects without tissue ablation. The analysis of clinical studies shows a great variety of different results. The main reason for this fact is that the design of past and present studies ignored the pathophysiological aspects of BPS, especially the obstructive component, and the fact that the outcome of most procedures more or less depends on the operator/user.

Entities:  

Mesh:

Year:  2008        PMID: 18265958     DOI: 10.1007/s00120-008-1630-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  8 in total

1.  [Guideline by German urologists on therapy of benign prostatic hypertrophy syndrome. German SOciety of Urology].

Authors: 
Journal:  Urologe A       Date:  1999-09       Impact factor: 0.639

2.  [Guidelines for German urologists on diagnosis of benign prostate syndrome].

Authors:  R Berges; K Dreikorn; K Höfner; U Jonas; K U Laval; S Madersbacher; M C Michel; R Muschter; M Oelke; L Pientka; C Tschuschke; U Tunn; K Schalkhäuser; B Göckel-Beining; A Heidenreich; H Rübben; K Schalkhäuser; W Thon; J Thüroff; W Weidner
Journal:  Urologe A       Date:  2003-03-12       Impact factor: 0.639

3.  [Guidelines of German urologists on therapy of benign prostate syndrome].

Authors:  R Berges; K Dreikorn; K Höfner; U Jonas; K U Laval; S Madersbacher; M C Michel; R Muschter; M Oelke; L Pientka; C Tschuschke; U Tunn; H Palmtag; M Goepel; K Schalhhäuser; B Göckeel-Beining; A Heidenreich; H Rübben; K Schalkerhäuser; W Thon; J Thüroff; W Weidner
Journal:  Urologe A       Date:  2003-03-22       Impact factor: 0.639

Review 4.  Current role of lasers in the treatment of benign prostatic hyperplasia (BPH).

Authors:  Rainer M Kuntz
Journal:  Eur Urol       Date:  2006-03-31       Impact factor: 20.096

Review 5.  Techniques and long-term results of surgical procedures for BPH.

Authors:  Oliver Reich; Christian Gratzke; Christian G Stief
Journal:  Eur Urol       Date:  2006-02-06       Impact factor: 20.096

6.  A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia.

Authors:  Peter Boyle; Christopher Robertson; E Darracott Vaughan; John M Fitzpatrick
Journal:  BJU Int       Date:  2004-07       Impact factor: 5.588

Review 7.  Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review.

Authors:  Richard M Hoffman; Roderick MacDonald; Manoj Monga; Timothy J Wilt
Journal:  BJU Int       Date:  2004-11       Impact factor: 5.588

Review 8.  Lasers for median lobe hyperplasia.

Authors:  R Muschter; A P Gilling
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

  8 in total
  1 in total

1.  [The 69th Congress-urologists nominated for the Nobel Prize : Not everyone got a prize: four biographical sketches].

Authors:  F H Moll; T Halling; M Krischel; N Hansson; H Fangerau
Journal:  Urologe A       Date:  2017-09       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.